Paul Tudor Jones’s Takeda Pharmaceutical TAK Stock Holding History

Paul Tudor Jones’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.61M	Buy	+100,149	New	+$1.66M	﹤0.01%	2094
2024 Q1	–	Sell	-18,724	Closed	-$267K	–	2768
2023 Q4	$267K	Buy	+18,724	New	+$266K	﹤0.01%	2080
2023 Q3	–	Sell	-170,818	Closed	-$2.68M	–	2858
2023 Q2	$2.68M	Buy	170,818 +59,877	+54%	+$981K	0.03%	731
2023 Q1	$1.83M	Buy	+110,941	New	+$1.77M	0.03%	843
2020 Q1	–	Sell	-437,923	Closed	-$8.64M	–	1322
2019 Q4	$8.64M	Buy	437,923 +1,451	+0.3%	+$27.8K	0.39%	37
2019 Q3	$7.51M	Buy	+436,472	New	+$7.55M	0.26%	70
2019 Q2	–	Sell	-1,279,098	Closed	-$26.1M	–	1328
2019 Q1	$26.1M	Buy	+1,279,098	New	+$25.7M	1.08%	10

Other funds holding TAK

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Paul Tudor Jones's TAK Position: Q2 2026 in Review

Paul Tudor Jones opened a new position in Takeda Pharmaceutical (TAK) in Q2 2026: 100,149 shares worth $1.61M. The stake represents ﹤0.01% of the portfolio and ranks #2094 among its holdings. This is a return to the name: Paul Tudor Jones previously reported a position in TAK as recently as Q4 2023.

Paul Tudor Jones first reported a position in TAK in Q1 2019 and has held it in 7 quarters since. The position peaked at $26.1M in Q1 2019. 375 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

Paul Tudor Jones held 100,149 shares of Takeda Pharmaceutical worth $1.61M as of Q2 2026.
Takeda Pharmaceutical was a new Paul Tudor Jones position in Q2 2026.
Takeda Pharmaceutical made up ﹤0.01% of Paul Tudor Jones's portfolio in Q2 2026, its #2094 holding.
Paul Tudor Jones first reported a position in Takeda Pharmaceutical in Q1 2019 and has held it in 7 quarters since.
Paul Tudor Jones's Takeda Pharmaceutical position peaked at $26.1M in Q1 2019.
375 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.